Seagen Inc

+0.58 (+0.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)22.98B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$406.95 Million
Adjusted EPS-$0.82
See more estimates
10-Day MA$132.02
50-Day MA$152.70
200-Day MA$156.22
See more pivots

Seagen Inc Stock, NASDAQ:SGEN

21823-30th Drive SE, Bothell, Bothell, Washington 98021
United States of America
Phone: +1.425.527.4000
Number of Employees: 2092


Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.